Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid Tumors

    NEXT STORY
    Teleflex to Present at the 9th Annual SVB Leerink Global Healthcare Conference
    PREV STORY
    The global medical headwalls market is expected to reach US$ 1,318.68 Mn in 2027 from US$ 826.80 Mn in 2018
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Heather Rowe Named Dynavax’s Vice President of Investor Relations and Corporate Communications

    BERKELEY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a ...

    author_avatar
    NASDAQ Market News

    Translate Bio Presents MRT5005 Data at the 33rd Annual North American Cystic Fibrosis Conference

    author_avatar
    NASDAQ Market News

    Athenex, Inc. Announces Second Quarter 2017 Results

    Received Chinese FDA approval to begin clinical trials of KX-02 Tablet for GlioblastomaBegan patient ...

    author_avatar
    NASDAQ Market News